SEC Tracker
Get the app

Allarity Therapeutics ALLR

Allarity Therapeutics: signs a material agreement, takes on a new financial obligation and 3 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Changes shareholder rights (3.03)
  • Amends its charter or bylaws (5.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Allarity Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025
  2. Akari Therapeutics AKTX public float $15M, Jun 30, 2025
  3. ProPhase Labs PRPH public float $15M, Jun 30, 2025
  4. Pluri PLUR public float $15M, Dec 31, 2025
  5. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old